$2.01
+0.10 (+5.24%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+543.3% upside
Low Target
$7.67
Average Target
$12.93
High Target
$16.62
Current Price
$2.01
Current
$2.01
$2.01
Target
$12.93
$12.93
$7.67
$12.93 avg
$16.62
Scenario Analysis
Bear Case
$7.67
281.6%
Low target
Base Case
$12.93
+543.3%
Avg target
Bull Case
$16.62
+726.9%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$4.53
-55.6% from high
52-Week Low
$1.79
+12.3% from low
Target vs 52W High
$12.93
+185.4% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.7% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.8% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.6% |
| REGN | Buy | 36 | 72% | $76.80 | -92.0% |
| MRNA | Hold | 31 | 32% | $149.45 | -33.1% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.2% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -33.8% |